| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anxiety Disorders | 47 | 2008 | 426 | 4.010 |
Why?
|
| Panic Disorder | 44 | 2008 | 121 | 3.650 |
Why?
|
| Depressive Disorder | 46 | 2002 | 621 | 2.210 |
Why?
|
| Phobic Disorders | 31 | 2004 | 227 | 1.700 |
Why?
|
| Panic | 26 | 1992 | 97 | 1.470 |
Why?
|
| Alprazolam | 22 | 2003 | 35 | 1.140 |
Why?
|
| Bipolar Disorder | 30 | 2007 | 307 | 0.960 |
Why?
|
| Psychiatric Status Rating Scales | 39 | 2008 | 782 | 0.960 |
Why?
|
| Anti-Anxiety Agents | 12 | 2003 | 107 | 0.940 |
Why?
|
| Fear | 18 | 2000 | 239 | 0.920 |
Why?
|
| Agoraphobia | 23 | 1999 | 59 | 0.910 |
Why?
|
| Carbamazepine | 22 | 2007 | 108 | 0.900 |
Why?
|
| Substance Withdrawal Syndrome | 13 | 2003 | 435 | 0.750 |
Why?
|
| Benzodiazepines | 11 | 2001 | 130 | 0.660 |
Why?
|
| Colonic Diseases, Functional | 7 | 2001 | 9 | 0.640 |
Why?
|
| Obsessive-Compulsive Disorder | 11 | 2008 | 88 | 0.610 |
Why?
|
| Humans | 199 | 2008 | 68618 | 0.590 |
Why?
|
| Bulimia | 7 | 1995 | 72 | 0.580 |
Why?
|
| Adult | 122 | 2008 | 21403 | 0.570 |
Why?
|
| Mental Disorders | 14 | 2001 | 659 | 0.560 |
Why?
|
| Comorbidity | 24 | 2001 | 1426 | 0.520 |
Why?
|
| Antidepressive Agents | 10 | 2002 | 216 | 0.500 |
Why?
|
| Antidepressive Agents, Tricyclic | 9 | 2001 | 45 | 0.470 |
Why?
|
| Treatment Outcome | 30 | 2008 | 7029 | 0.470 |
Why?
|
| Imipramine | 11 | 1996 | 44 | 0.450 |
Why?
|
| Female | 115 | 2008 | 38074 | 0.420 |
Why?
|
| Male | 111 | 2008 | 37321 | 0.400 |
Why?
|
| Paroxetine | 2 | 2004 | 28 | 0.400 |
Why?
|
| Primary Health Care | 7 | 2001 | 703 | 0.390 |
Why?
|
| Arousal | 10 | 1995 | 168 | 0.370 |
Why?
|
| Electric Stimulation Therapy | 3 | 2000 | 147 | 0.360 |
Why?
|
| Middle Aged | 74 | 2008 | 21147 | 0.350 |
Why?
|
| Monoamine Oxidase Inhibitors | 7 | 1998 | 30 | 0.330 |
Why?
|
| Psychiatry | 6 | 2001 | 112 | 0.320 |
Why?
|
| Stress Disorders, Post-Traumatic | 6 | 2008 | 1506 | 0.300 |
Why?
|
| Treatment Failure | 1 | 2008 | 216 | 0.300 |
Why?
|
| Sleep Deprivation | 2 | 1998 | 81 | 0.300 |
Why?
|
| Anticonvulsants | 3 | 2006 | 223 | 0.290 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2008 | 61 | 0.290 |
Why?
|
| Antimanic Agents | 1 | 2007 | 21 | 0.280 |
Why?
|
| Lithium | 9 | 1990 | 76 | 0.270 |
Why?
|
| Practice Guidelines as Topic | 4 | 2007 | 772 | 0.270 |
Why?
|
| Double-Blind Method | 24 | 1999 | 1738 | 0.270 |
Why?
|
| Community Mental Health Services | 2 | 2001 | 65 | 0.260 |
Why?
|
| Prevalence | 12 | 2001 | 1619 | 0.260 |
Why?
|
| Ethanol | 4 | 2001 | 893 | 0.250 |
Why?
|
| Brain | 12 | 2008 | 2176 | 0.240 |
Why?
|
| Fluvoxamine | 3 | 1993 | 22 | 0.240 |
Why?
|
| Drug Administration Schedule | 13 | 1999 | 567 | 0.240 |
Why?
|
| Clinical Trials as Topic | 15 | 2008 | 848 | 0.230 |
Why?
|
| Carbolines | 3 | 1997 | 19 | 0.230 |
Why?
|
| Personality Disorders | 5 | 2003 | 44 | 0.230 |
Why?
|
| International Cooperation | 1 | 2004 | 88 | 0.230 |
Why?
|
| Depressive Disorder, Major | 3 | 2008 | 439 | 0.220 |
Why?
|
| Aged | 34 | 2004 | 14862 | 0.220 |
Why?
|
| Vagus Nerve | 2 | 2000 | 90 | 0.210 |
Why?
|
| Pyridoxal Phosphate | 2 | 1994 | 9 | 0.210 |
Why?
|
| Placebos | 9 | 2004 | 195 | 0.200 |
Why?
|
| Adolescent | 28 | 2004 | 8912 | 0.200 |
Why?
|
| Alcoholism | 9 | 1999 | 1109 | 0.200 |
Why?
|
| Substance-Related Disorders | 6 | 1995 | 1242 | 0.200 |
Why?
|
| Neurocognitive Disorders | 2 | 1992 | 23 | 0.200 |
Why?
|
| Affective Disorders, Psychotic | 7 | 1988 | 23 | 0.200 |
Why?
|
| Personality Inventory | 10 | 2003 | 197 | 0.200 |
Why?
|
| Diagnosis, Differential | 9 | 2002 | 1140 | 0.190 |
Why?
|
| Anxiety | 5 | 2004 | 422 | 0.190 |
Why?
|
| Bupropion | 3 | 2003 | 63 | 0.190 |
Why?
|
| Ambulatory Care Facilities | 1 | 2001 | 91 | 0.180 |
Why?
|
| Research | 2 | 2000 | 214 | 0.180 |
Why?
|
| Expert Testimony | 1 | 2000 | 47 | 0.180 |
Why?
|
| Cross-Cultural Comparison | 1 | 2001 | 68 | 0.180 |
Why?
|
| Electromagnetic Fields | 1 | 2000 | 66 | 0.180 |
Why?
|
| Combined Modality Therapy | 7 | 2008 | 951 | 0.180 |
Why?
|
| Wounds and Injuries | 1 | 2004 | 334 | 0.180 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2000 | 54 | 0.180 |
Why?
|
| Schizophrenia | 12 | 1990 | 206 | 0.180 |
Why?
|
| Homovanillic Acid | 6 | 1994 | 52 | 0.170 |
Why?
|
| Program Development | 1 | 2000 | 240 | 0.170 |
Why?
|
| Pilot Projects | 6 | 2008 | 1342 | 0.160 |
Why?
|
| Cerebral Ventricles | 1 | 1998 | 36 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 3 | 1996 | 189 | 0.160 |
Why?
|
| Patient Satisfaction | 1 | 2001 | 378 | 0.160 |
Why?
|
| Cocaine | 4 | 1991 | 555 | 0.150 |
Why?
|
| Prefrontal Cortex | 2 | 2000 | 640 | 0.150 |
Why?
|
| Depression | 7 | 2000 | 943 | 0.150 |
Why?
|
| Desipramine | 3 | 1993 | 47 | 0.150 |
Why?
|
| Central Nervous System Depressants | 1 | 1999 | 182 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 1 | 1999 | 296 | 0.150 |
Why?
|
| Amygdala | 2 | 1998 | 159 | 0.150 |
Why?
|
| Pentagastrin | 1 | 1997 | 16 | 0.150 |
Why?
|
| Severity of Illness Index | 7 | 2003 | 1851 | 0.140 |
Why?
|
| Norepinephrine | 12 | 1995 | 276 | 0.140 |
Why?
|
| beta-Endorphin | 6 | 1992 | 15 | 0.140 |
Why?
|
| Fluoxetine | 2 | 1999 | 40 | 0.140 |
Why?
|
| Somatoform Disorders | 2 | 1995 | 35 | 0.140 |
Why?
|
| Cyclohexanols | 1 | 1996 | 12 | 0.140 |
Why?
|
| Quality of Life | 4 | 2000 | 1515 | 0.140 |
Why?
|
| Psychotropic Drugs | 3 | 2001 | 83 | 0.140 |
Why?
|
| 1-Naphthylamine | 1 | 1995 | 11 | 0.130 |
Why?
|
| Psychometrics | 5 | 2001 | 514 | 0.130 |
Why?
|
| Serotonin | 6 | 1995 | 144 | 0.130 |
Why?
|
| Prognosis | 5 | 2004 | 2093 | 0.130 |
Why?
|
| Desensitization, Psychologic | 2 | 1993 | 7 | 0.130 |
Why?
|
| Isatin | 1 | 1995 | 3 | 0.130 |
Why?
|
| Dynorphins | 2 | 1992 | 69 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2003 | 1745 | 0.120 |
Why?
|
| Surveys and Questionnaires | 2 | 2001 | 2800 | 0.120 |
Why?
|
| Valproic Acid | 1 | 1995 | 93 | 0.120 |
Why?
|
| Sincalide | 2 | 1993 | 12 | 0.120 |
Why?
|
| Referral and Consultation | 4 | 2001 | 383 | 0.120 |
Why?
|
| Follow-Up Studies | 9 | 2001 | 3259 | 0.120 |
Why?
|
| Psychoses, Substance-Induced | 3 | 1991 | 20 | 0.110 |
Why?
|
| Kindling, Neurologic | 4 | 1988 | 24 | 0.110 |
Why?
|
| Somatostatin | 6 | 1985 | 36 | 0.110 |
Why?
|
| Psychophysiologic Disorders | 1 | 1993 | 20 | 0.110 |
Why?
|
| Receptors, Cholinergic | 1 | 1993 | 30 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2001 | 940 | 0.110 |
Why?
|
| Job Description | 1 | 1993 | 23 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2004 | 2223 | 0.110 |
Why?
|
| Models, Nursing | 1 | 1993 | 23 | 0.110 |
Why?
|
| Nurse Clinicians | 1 | 1993 | 20 | 0.110 |
Why?
|
| Consultants | 1 | 1993 | 12 | 0.110 |
Why?
|
| Catecholamines | 1 | 1993 | 73 | 0.110 |
Why?
|
| Phenelzine | 3 | 1989 | 7 | 0.110 |
Why?
|
| Psychiatric Nursing | 1 | 1993 | 33 | 0.110 |
Why?
|
| Patient Dropouts | 5 | 2003 | 98 | 0.110 |
Why?
|
| Lorazepam | 2 | 1989 | 54 | 0.110 |
Why?
|
| Mood Disorders | 5 | 1986 | 132 | 0.100 |
Why?
|
| Cardiovascular System | 1 | 1993 | 85 | 0.100 |
Why?
|
| Telemedicine | 1 | 2000 | 700 | 0.100 |
Why?
|
| Sleep Stages | 3 | 1989 | 30 | 0.100 |
Why?
|
| Neurocirculatory Asthenia | 1 | 1992 | 1 | 0.100 |
Why?
|
| ABO Blood-Group System | 1 | 1992 | 15 | 0.100 |
Why?
|
| Voyeurism | 1 | 1991 | 1 | 0.100 |
Why?
|
| Social Behavior Disorders | 1 | 1991 | 16 | 0.100 |
Why?
|
| Pergolide | 1 | 1991 | 12 | 0.090 |
Why?
|
| Smoking | 1 | 1999 | 1452 | 0.090 |
Why?
|
| Cholecystokinin | 3 | 1997 | 29 | 0.090 |
Why?
|
| Stereotyping | 2 | 2001 | 20 | 0.090 |
Why?
|
| Nortriptyline | 1 | 1990 | 28 | 0.090 |
Why?
|
| Neural Pathways | 4 | 2000 | 324 | 0.090 |
Why?
|
| Disability Evaluation | 3 | 1997 | 298 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2001 | 2077 | 0.090 |
Why?
|
| Clinical Protocols | 4 | 1998 | 172 | 0.090 |
Why?
|
| Endorphins | 8 | 1992 | 32 | 0.090 |
Why?
|
| Neoplasms | 1 | 2001 | 1667 | 0.080 |
Why?
|
| Age of Onset | 3 | 2001 | 188 | 0.080 |
Why?
|
| Cost of Illness | 3 | 2000 | 206 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 1992 | 286 | 0.080 |
Why?
|
| Alcohol Withdrawal Delirium | 2 | 1989 | 24 | 0.080 |
Why?
|
| Oximes | 1 | 1989 | 10 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 7 | 1995 | 208 | 0.080 |
Why?
|
| Defecation | 1 | 1988 | 8 | 0.080 |
Why?
|
| Medical Indigency | 1 | 1988 | 7 | 0.080 |
Why?
|
| Psychiatric Department, Hospital | 1 | 1988 | 17 | 0.080 |
Why?
|
| Secondary Prevention | 3 | 1999 | 291 | 0.080 |
Why?
|
| Hospitalization | 8 | 1995 | 978 | 0.080 |
Why?
|
| Psychoses, Alcoholic | 1 | 1988 | 5 | 0.080 |
Why?
|
| Headache | 2 | 1998 | 68 | 0.080 |
Why?
|
| Public Health Administration | 1 | 1988 | 36 | 0.080 |
Why?
|
| Tryptophan | 1 | 1988 | 65 | 0.070 |
Why?
|
| Recurrence | 4 | 1996 | 948 | 0.070 |
Why?
|
| Reference Values | 3 | 1995 | 579 | 0.070 |
Why?
|
| Dopamine | 6 | 1995 | 474 | 0.070 |
Why?
|
| Behavior Therapy | 4 | 1994 | 297 | 0.070 |
Why?
|
| Risk Factors | 6 | 2004 | 5731 | 0.070 |
Why?
|
| Psychotherapy | 3 | 2002 | 253 | 0.070 |
Why?
|
| Libido | 1 | 1987 | 7 | 0.070 |
Why?
|
| Penile Erection | 1 | 1987 | 18 | 0.070 |
Why?
|
| Drug Evaluation | 1 | 2007 | 47 | 0.070 |
Why?
|
| Age Factors | 4 | 1997 | 1864 | 0.070 |
Why?
|
| Methoxyhydroxyphenylglycol | 6 | 1993 | 41 | 0.070 |
Why?
|
| Electroencephalography | 1 | 1989 | 418 | 0.070 |
Why?
|
| Health Education | 2 | 1999 | 279 | 0.070 |
Why?
|
| Acute Disease | 3 | 2006 | 658 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2006 | 931 | 0.060 |
Why?
|
| Locus Coeruleus | 3 | 2000 | 55 | 0.060 |
Why?
|
| Health Care Costs | 2 | 1999 | 346 | 0.060 |
Why?
|
| Urea | 1 | 2004 | 51 | 0.060 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1984 | 4 | 0.060 |
Why?
|
| Dibenzoxazepines | 1 | 1984 | 6 | 0.060 |
Why?
|
| Amoxapine | 1 | 1984 | 7 | 0.060 |
Why?
|
| Family Practice | 2 | 1998 | 312 | 0.060 |
Why?
|
| Gyrus Cinguli | 2 | 1999 | 113 | 0.060 |
Why?
|
| South Carolina | 3 | 2001 | 2752 | 0.060 |
Why?
|
| Drug Therapy, Combination | 4 | 1990 | 649 | 0.060 |
Why?
|
| Bundle-Branch Block | 1 | 1984 | 50 | 0.060 |
Why?
|
| Speech | 1 | 2004 | 118 | 0.060 |
Why?
|
| Child | 4 | 2004 | 6405 | 0.050 |
Why?
|
| Sex Factors | 5 | 1993 | 1266 | 0.050 |
Why?
|
| Affective Symptoms | 2 | 1979 | 50 | 0.050 |
Why?
|
| Arginine Vasopressin | 4 | 1983 | 16 | 0.050 |
Why?
|
| Electroconvulsive Therapy | 2 | 2000 | 402 | 0.050 |
Why?
|
| United States | 6 | 1999 | 7367 | 0.050 |
Why?
|
| Ambulatory Care | 2 | 1997 | 340 | 0.050 |
Why?
|
| Clomipramine | 2 | 1991 | 8 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2004 | 1054 | 0.050 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2003 | 152 | 0.050 |
Why?
|
| Psychotherapeutic Processes | 1 | 2001 | 4 | 0.050 |
Why?
|
| Attitude to Health | 2 | 1996 | 403 | 0.050 |
Why?
|
| Policy Making | 1 | 2001 | 51 | 0.050 |
Why?
|
| Remission Induction | 1 | 2001 | 111 | 0.050 |
Why?
|
| Dopamine beta-Hydroxylase | 4 | 1983 | 24 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2001 | 47 | 0.050 |
Why?
|
| Consumer Behavior | 1 | 2000 | 68 | 0.050 |
Why?
|
| Physicians, Family | 1 | 2000 | 83 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2004 | 310 | 0.040 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 1996 | 79 | 0.040 |
Why?
|
| Ethics, Medical | 1 | 2000 | 86 | 0.040 |
Why?
|
| Social Welfare | 1 | 2000 | 11 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2001 | 141 | 0.040 |
Why?
|
| Medical Oncology | 1 | 2001 | 110 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2001 | 220 | 0.040 |
Why?
|
| Limbic System | 2 | 1999 | 106 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 1996 | 4848 | 0.040 |
Why?
|
| Spinal Puncture | 1 | 1979 | 38 | 0.040 |
Why?
|
| Crying | 1 | 1999 | 6 | 0.040 |
Why?
|
| Brain Mapping | 3 | 2004 | 532 | 0.040 |
Why?
|
| Maternal Behavior | 1 | 1999 | 29 | 0.040 |
Why?
|
| Disease Management | 1 | 2000 | 248 | 0.040 |
Why?
|
| Health Policy | 1 | 2001 | 221 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 137 | 0.040 |
Why?
|
| Heart Rate | 3 | 1993 | 568 | 0.040 |
Why?
|
| Body Weight | 2 | 1993 | 554 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 504 | 0.040 |
Why?
|
| Mental Health Services | 1 | 2000 | 199 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2004 | 1553 | 0.040 |
Why?
|
| Temporal Lobe | 1 | 1999 | 125 | 0.040 |
Why?
|
| Time Factors | 3 | 1996 | 4655 | 0.040 |
Why?
|
| Hydroxyindoleacetic Acid | 4 | 1990 | 36 | 0.040 |
Why?
|
| Receptors, Cholecystokinin | 2 | 1995 | 8 | 0.040 |
Why?
|
| Stress, Psychological | 2 | 2004 | 824 | 0.040 |
Why?
|
| World Health Organization | 1 | 1998 | 53 | 0.040 |
Why?
|
| Hydrocortisone | 4 | 1985 | 291 | 0.040 |
Why?
|
| Implosive Therapy | 1 | 2000 | 171 | 0.040 |
Why?
|
| Life Change Events | 2 | 1996 | 223 | 0.040 |
Why?
|
| Caregivers | 1 | 2001 | 365 | 0.040 |
Why?
|
| Electrocardiography | 2 | 1993 | 601 | 0.040 |
Why?
|
| Young Adult | 1 | 2008 | 5717 | 0.040 |
Why?
|
| Epilepsy | 2 | 2000 | 336 | 0.030 |
Why?
|
| Medicine | 1 | 1997 | 52 | 0.030 |
Why?
|
| Specialization | 1 | 1997 | 66 | 0.030 |
Why?
|
| Glycols | 3 | 1981 | 9 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 1997 | 334 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 1997 | 49 | 0.030 |
Why?
|
| Pituitary Gland, Anterior | 2 | 1986 | 10 | 0.030 |
Why?
|
| Venlafaxine Hydrochloride | 1 | 1996 | 42 | 0.030 |
Why?
|
| Patient Care Team | 3 | 1995 | 311 | 0.030 |
Why?
|
| Patient Compliance | 3 | 1993 | 402 | 0.030 |
Why?
|
| National Institute of Mental Health (U.S.) | 2 | 1994 | 8 | 0.030 |
Why?
|
| Phenylacetates | 3 | 1981 | 18 | 0.030 |
Why?
|
| Sertraline | 1 | 1995 | 62 | 0.030 |
Why?
|
| Benzodiazepinones | 1 | 1995 | 4 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 1995 | 31 | 0.030 |
Why?
|
| Thyrotropin-Releasing Hormone | 2 | 1993 | 25 | 0.030 |
Why?
|
| Biomarkers | 1 | 2001 | 1593 | 0.030 |
Why?
|
| Receptors, Dopamine | 3 | 1991 | 119 | 0.030 |
Why?
|
| Psychotic Disorders | 5 | 1983 | 157 | 0.030 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 1995 | 151 | 0.030 |
Why?
|
| Community Mental Health Centers | 1 | 1994 | 16 | 0.030 |
Why?
|
| Public Sector | 1 | 1994 | 19 | 0.030 |
Why?
|
| Hypotension, Orthostatic | 1 | 1993 | 15 | 0.030 |
Why?
|
| Pulse | 1 | 1993 | 23 | 0.030 |
Why?
|
| Normetanephrine | 1 | 1993 | 8 | 0.030 |
Why?
|
| Vanilmandelic Acid | 1 | 1993 | 6 | 0.030 |
Why?
|
| Metanephrine | 1 | 1993 | 11 | 0.030 |
Why?
|
| Random Allocation | 3 | 1989 | 442 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 1995 | 236 | 0.030 |
Why?
|
| Receptors, Adrenergic | 1 | 1993 | 68 | 0.030 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1993 | 40 | 0.030 |
Why?
|
| Pteridines | 2 | 1983 | 5 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2003 | 3705 | 0.030 |
Why?
|
| Biopterin | 2 | 1983 | 10 | 0.030 |
Why?
|
| Lithium Carbonate | 4 | 1986 | 31 | 0.030 |
Why?
|
| Eating | 1 | 1993 | 119 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 1994 | 281 | 0.030 |
Why?
|
| Central Nervous System | 2 | 1984 | 107 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2004 | 7277 | 0.030 |
Why?
|
| Pacemaker, Artificial | 1 | 1973 | 157 | 0.030 |
Why?
|
| Paranoid Disorders | 1 | 1991 | 9 | 0.030 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 1992 | 34 | 0.030 |
Why?
|
| Delusions | 1 | 1991 | 20 | 0.030 |
Why?
|
| Hallucinations | 1 | 1991 | 19 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 1992 | 40 | 0.030 |
Why?
|
| Stereotyped Behavior | 1 | 1991 | 42 | 0.030 |
Why?
|
| Schizophrenic Psychology | 4 | 1990 | 53 | 0.020 |
Why?
|
| Genetic Markers | 1 | 1992 | 144 | 0.020 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1991 | 30 | 0.020 |
Why?
|
| Personality | 2 | 1984 | 66 | 0.020 |
Why?
|
| Cyclic GMP | 2 | 1982 | 99 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 1991 | 88 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 1753 | 0.020 |
Why?
|
| Incidence | 1 | 1996 | 1603 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1996 | 468 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 1991 | 187 | 0.020 |
Why?
|
| Delayed-Action Preparations | 2 | 2003 | 120 | 0.020 |
Why?
|
| Feeding and Eating Disorders | 1 | 1993 | 106 | 0.020 |
Why?
|
| Decision Trees | 1 | 1991 | 74 | 0.020 |
Why?
|
| Corpus Callosum | 1 | 1991 | 29 | 0.020 |
Why?
|
| Caudate Nucleus | 1 | 1991 | 56 | 0.020 |
Why?
|
| Exercise Test | 1 | 1992 | 242 | 0.020 |
Why?
|
| Patient Participation | 1 | 1992 | 146 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 1993 | 425 | 0.020 |
Why?
|
| Child Rearing | 1 | 1990 | 8 | 0.020 |
Why?
|
| Models, Neurological | 2 | 1989 | 136 | 0.020 |
Why?
|
| Gastrointestinal Diseases | 1 | 1991 | 107 | 0.020 |
Why?
|
| Biogenic Monoamines | 1 | 1990 | 18 | 0.020 |
Why?
|
| Aggression | 2 | 1981 | 98 | 0.020 |
Why?
|
| Pituitary Hormones, Anterior | 2 | 1986 | 2 | 0.020 |
Why?
|
| Prostaglandins E | 1 | 1989 | 54 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 1990 | 98 | 0.020 |
Why?
|
| Oxazepam | 1 | 1989 | 3 | 0.020 |
Why?
|
| Receptors, Opioid | 4 | 1983 | 60 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1992 | 597 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 1996 | 2279 | 0.020 |
Why?
|
| Psychological Theory | 1 | 1989 | 27 | 0.020 |
Why?
|
| Brain Injuries | 1 | 1992 | 268 | 0.020 |
Why?
|
| Delta Rhythm | 1 | 1989 | 11 | 0.020 |
Why?
|
| Autonomic Nervous System | 1 | 1989 | 31 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1991 | 483 | 0.020 |
Why?
|
| Animals | 6 | 1998 | 20881 | 0.020 |
Why?
|
| Hospital Bed Capacity, 100 to 299 | 1 | 1988 | 3 | 0.020 |
Why?
|
| Commitment of Mentally Ill | 1 | 1988 | 15 | 0.020 |
Why?
|
| Disulfiram | 2 | 1979 | 22 | 0.020 |
Why?
|
| Blood Pressure | 2 | 1993 | 1451 | 0.020 |
Why?
|
| Sleep, REM | 1 | 1989 | 93 | 0.020 |
Why?
|
| Reaction Time | 1 | 1989 | 170 | 0.020 |
Why?
|
| Tranquilizing Agents | 1 | 1987 | 7 | 0.020 |
Why?
|
| Outpatients | 1 | 1989 | 127 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1988 | 193 | 0.020 |
Why?
|
| Decision Making | 1 | 1991 | 410 | 0.020 |
Why?
|
| Educational Status | 2 | 1999 | 273 | 0.020 |
Why?
|
| Radioligand Assay | 5 | 1991 | 109 | 0.020 |
Why?
|
| Cerebral Cortex | 2 | 1988 | 415 | 0.020 |
Why?
|
| Sexual Dysfunctions, Psychological | 1 | 1987 | 17 | 0.020 |
Why?
|
| Pregnancy | 1 | 1992 | 2334 | 0.020 |
Why?
|
| Piribedil | 1 | 1986 | 1 | 0.020 |
Why?
|
| Behavior | 1 | 1986 | 59 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 2 | 1983 | 43 | 0.020 |
Why?
|
| Mitral Valve Prolapse | 1 | 1986 | 40 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 1987 | 183 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 1986 | 67 | 0.020 |
Why?
|
| Models, Psychological | 1 | 1986 | 180 | 0.020 |
Why?
|
| Zimeldine | 1 | 1985 | 1 | 0.020 |
Why?
|
| Peroxides | 1 | 2004 | 23 | 0.020 |
Why?
|
| MMPI | 2 | 1985 | 40 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1985 | 150 | 0.010 |
Why?
|
| Piperazines | 1 | 1986 | 206 | 0.010 |
Why?
|
| Calcitonin | 2 | 1982 | 21 | 0.010 |
Why?
|
| Seizures | 2 | 1992 | 279 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1984 | 289 | 0.010 |
Why?
|
| Tetragastrin | 2 | 1995 | 3 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 304 | 0.010 |
Why?
|
| Pituitary Hormones | 1 | 1984 | 16 | 0.010 |
Why?
|
| Blood Platelets | 2 | 1982 | 284 | 0.010 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1983 | 21 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 1984 | 119 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1983 | 136 | 0.010 |
Why?
|
| Deamino Arginine Vasopressin | 2 | 1981 | 15 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 1992 | 150 | 0.010 |
Why?
|
| Risk | 1 | 1984 | 563 | 0.010 |
Why?
|
| Aging | 2 | 1996 | 911 | 0.010 |
Why?
|
| Internship and Residency | 2 | 1994 | 596 | 0.010 |
Why?
|
| Pituitary Gland, Posterior | 1 | 1983 | 2 | 0.010 |
Why?
|
| Regression Analysis | 2 | 1997 | 737 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 1983 | 31 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1984 | 383 | 0.010 |
Why?
|
| Social Adjustment | 3 | 1994 | 74 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1982 | 223 | 0.010 |
Why?
|
| Sleep | 2 | 1983 | 263 | 0.010 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2003 | 257 | 0.010 |
Why?
|
| Pimozide | 1 | 1981 | 3 | 0.010 |
Why?
|
| Internal Medicine | 1 | 1982 | 118 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 1989 | 106 | 0.010 |
Why?
|
| Schools, Medical | 1 | 1982 | 157 | 0.010 |
Why?
|
| Enkephalins | 1 | 1981 | 89 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 689 | 0.010 |
Why?
|
| Anorexia Nervosa | 1 | 1982 | 52 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1982 | 142 | 0.010 |
Why?
|
| Solitary Nucleus | 1 | 2000 | 3 | 0.010 |
Why?
|
| Education, Medical, Undergraduate | 1 | 1982 | 148 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 1981 | 41 | 0.010 |
Why?
|
| Cyproheptadine | 1 | 1980 | 6 | 0.010 |
Why?
|
| Hysteria | 1 | 1980 | 1 | 0.010 |
Why?
|
| Hypochondriasis | 1 | 1980 | 3 | 0.010 |
Why?
|
| Cost Allocation | 1 | 1999 | 4 | 0.010 |
Why?
|
| Direct Service Costs | 1 | 1999 | 8 | 0.010 |
Why?
|
| Heart | 1 | 1984 | 850 | 0.010 |
Why?
|
| Managed Care Programs | 1 | 1999 | 45 | 0.010 |
Why?
|
| Marital Status | 1 | 1999 | 65 | 0.010 |
Why?
|
| Memory | 1 | 1981 | 214 | 0.010 |
Why?
|
| Peptides | 1 | 1982 | 455 | 0.010 |
Why?
|
| Rats | 2 | 1986 | 5300 | 0.010 |
Why?
|
| Models, Economic | 1 | 1999 | 69 | 0.010 |
Why?
|
| Cognition | 2 | 1981 | 513 | 0.010 |
Why?
|
| Family Characteristics | 1 | 1999 | 44 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 1038 | 0.010 |
Why?
|
| Object Attachment | 1 | 1999 | 20 | 0.010 |
Why?
|
| Learning | 1 | 1981 | 186 | 0.010 |
Why?
|
| Posture | 1 | 1979 | 107 | 0.010 |
Why?
|
| Pituitary-Adrenal System | 2 | 1992 | 138 | 0.010 |
Why?
|
| Workplace | 1 | 1999 | 75 | 0.010 |
Why?
|
| Drug Costs | 1 | 1999 | 87 | 0.010 |
Why?
|
| Mother-Child Relations | 1 | 1999 | 43 | 0.010 |
Why?
|
| Probenecid | 3 | 1986 | 10 | 0.010 |
Why?
|
| Employment | 1 | 1999 | 154 | 0.010 |
Why?
|
| Schizophrenia, Paranoid | 2 | 1990 | 8 | 0.010 |
Why?
|
| Radioimmunoassay | 3 | 1981 | 164 | 0.010 |
Why?
|
| Domestic Violence | 1 | 1996 | 36 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 1999 | 652 | 0.010 |
Why?
|
| Neurotransmitter Agents | 2 | 1990 | 102 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 1986 | 32 | 0.010 |
Why?
|
| Pain | 1 | 1979 | 472 | 0.010 |
Why?
|
| Arginine | 2 | 1986 | 102 | 0.010 |
Why?
|
| Receptor, Cholecystokinin B | 1 | 1995 | 2 | 0.010 |
Why?
|
| Neurotic Disorders | 1 | 1995 | 13 | 0.010 |
Why?
|
| Contract Services | 1 | 1994 | 6 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1997 | 1040 | 0.010 |
Why?
|
| Health Status | 1 | 1997 | 429 | 0.010 |
Why?
|
| Interinstitutional Relations | 1 | 1994 | 49 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1996 | 295 | 0.010 |
Why?
|
| Career Choice | 1 | 1994 | 98 | 0.010 |
Why?
|
| Blood | 2 | 1983 | 40 | 0.010 |
Why?
|
| Osmolar Concentration | 2 | 1983 | 134 | 0.010 |
Why?
|
| Monoamine Oxidase | 2 | 1984 | 26 | 0.010 |
Why?
|
| Health Services Research | 1 | 1994 | 209 | 0.010 |
Why?
|
| Diazepam Binding Inhibitor | 1 | 1992 | 2 | 0.010 |
Why?
|
| Ventricular Fibrillation | 1 | 1973 | 85 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1999 | 2455 | 0.010 |
Why?
|
| Teaching | 1 | 1994 | 169 | 0.010 |
Why?
|
| Drug Tolerance | 1 | 1992 | 80 | 0.010 |
Why?
|
| Probability | 1 | 1992 | 245 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1992 | 107 | 0.010 |
Why?
|
| Receptors, GABA-A | 1 | 1992 | 89 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1973 | 219 | 0.010 |
Why?
|
| Personality Assessment | 1 | 1992 | 71 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1992 | 107 | 0.010 |
Why?
|
| Spiperone | 1 | 1991 | 29 | 0.010 |
Why?
|
| Sodium | 2 | 1983 | 161 | 0.010 |
Why?
|
| Antipsychotic Agents | 2 | 1983 | 247 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 1994 | 442 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1991 | 109 | 0.010 |
Why?
|
| Motivation | 1 | 1994 | 561 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1989 | 96 | 0.010 |
Why?
|
| Ataxia | 1 | 1988 | 11 | 0.000 |
Why?
|
| Social Environment | 1 | 1990 | 182 | 0.000 |
Why?
|
| Child Abuse, Sexual | 1 | 1990 | 150 | 0.000 |
Why?
|
| Family | 1 | 1990 | 293 | 0.000 |
Why?
|
| Fatigue | 1 | 1988 | 132 | 0.000 |
Why?
|
| Memory Disorders | 1 | 1988 | 111 | 0.000 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1988 | 131 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1986 | 31 | 0.000 |
Why?
|
| Growth Hormone | 1 | 1986 | 51 | 0.000 |
Why?
|
| Prolactin | 1 | 1986 | 61 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1986 | 29 | 0.000 |
Why?
|
| Triiodothyronine | 1 | 1986 | 22 | 0.000 |
Why?
|
| Thyrotropin | 1 | 1986 | 49 | 0.000 |
Why?
|
| Thyroxine | 1 | 1986 | 62 | 0.000 |
Why?
|
| Receptors, Adrenergic, alpha | 1 | 1985 | 40 | 0.000 |
Why?
|
| Agonistic Behavior | 1 | 1984 | 2 | 0.000 |
Why?
|
| Reflex | 1 | 1984 | 21 | 0.000 |
Why?
|
| Diuresis | 1 | 1983 | 20 | 0.000 |
Why?
|
| Sensation | 1 | 1984 | 49 | 0.000 |
Why?
|
| Reflex, Startle | 1 | 1984 | 39 | 0.000 |
Why?
|
| Evoked Potentials | 1 | 1984 | 61 | 0.000 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1984 | 52 | 0.000 |
Why?
|
| West Virginia | 1 | 1982 | 11 | 0.000 |
Why?
|
| Virginia | 1 | 1982 | 45 | 0.000 |
Why?
|
| Specialty Boards | 1 | 1982 | 24 | 0.000 |
Why?
|
| Vasotocin | 1 | 1982 | 1 | 0.000 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1982 | 19 | 0.000 |
Why?
|
| Angiotensins | 1 | 1982 | 16 | 0.000 |
Why?
|
| Substance P | 1 | 1982 | 39 | 0.000 |
Why?
|
| Vasopressins | 1 | 1982 | 33 | 0.000 |
Why?
|
| Amphetamine | 1 | 1982 | 77 | 0.000 |
Why?
|
| Tritium | 1 | 1981 | 101 | 0.000 |
Why?
|
| Biological Transport | 1 | 1981 | 210 | 0.000 |
Why?
|
| Macaca mulatta | 1 | 1981 | 77 | 0.000 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1980 | 4 | 0.000 |
Why?
|
| Oxytocin | 1 | 1982 | 124 | 0.000 |
Why?
|
| Chlorides | 1 | 1980 | 68 | 0.000 |
Why?
|
| Phosphates | 1 | 1980 | 72 | 0.000 |
Why?
|
| Mental Status Schedule | 1 | 1980 | 31 | 0.000 |
Why?
|
| Phenethylamines | 1 | 1980 | 20 | 0.000 |
Why?
|
| Binding Sites | 1 | 1981 | 631 | 0.000 |
Why?
|
| Potassium | 1 | 1980 | 168 | 0.000 |
Why?
|
| Magnesium | 1 | 1980 | 110 | 0.000 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1979 | 9 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1979 | 219 | 0.000 |
Why?
|
| Psychotherapy, Group | 1 | 1980 | 55 | 0.000 |
Why?
|
| Reference Standards | 1 | 1979 | 115 | 0.000 |
Why?
|
| Memory, Short-Term | 1 | 1979 | 79 | 0.000 |
Why?
|
| Hospitals, Psychiatric | 1 | 1978 | 59 | 0.000 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 1979 | 138 | 0.000 |
Why?
|
| Calcium | 1 | 1980 | 929 | 0.000 |
Why?
|